Investigators conducted a retrospective analysis to assess whether steatosis influences fibrosis progression in patients with hepatitis C virus infection. Journal of Viral Hepatitis
Contrary to current thinking, a new study suggests that proton pump inhibitors (PPIs) do not predispose to small intestinal bacterial overgrowth (SIBO). Reuters Health Information
In this video blog, Dr. John Marshall reflects on new data and evolving experience with bevacizumab in real patients with colorectal cancer. Medscape Hematology-Oncology
More than half of patients with ulcerative colitis refractory to aminosalicylate therapy respond to the biologic agent infliximab (Remicade) with complete mucosal healing. Reuters Health Information
U.S. drug reviewers highlighted safety issues with an experimental Merck & Co hepatitis drug, including anemia and reports of psychiatric problems, in documents released on Monday. Reuters Health Information
Interferon-alpha treatment after curative treatment of HCV-related hepatocellular carcinoma may reduce the recurrence rate of liver cancer. Journal of Viral Hepatitis